CAR T Cell Expansion Masquerading as Plasmacytosis: Case Report of Significant Lymphocytosis After Cilta‐Cel in Multiple Myeloma
ABSTRACT We report a case of delayed hypersensitivity dermatitis and an unusual lymphocyte expansion peaking at 45,000 cells/µL by Day +14 after ciltacabtagene autoleucel, a BCMA‐targeted CAR T therapy for multiple myeloma (MM). This marked post‐infusion lymphocytosis was initially mistaken for plasmacytosis but was confirmed by flow cytometry to be circulating CAR T cells. The lymphocytosis self‐resolved and was followed by complete remission. This case highlights that peripheral CAR T cell expansion may be mistaken for malignant plasmacytosis in the early post‐infusion period and underscores the critical role of flow cytometry in distinguishing CAR T cells from malignant plasma cells.
Authors
- Brian Vadasz
- Alyss Wilkey
- Adam Yuh Lin (ORCID: https://orcid.org/0000-0001-9359-882X)
- Julia Shapiro (ORCID: https://orcid.org/0000-0002-5521-2284)
- Kristy Wolniak (ORCID: https://orcid.org/0000-0001-6307-5489)
- George de Castro
- Fenlu Zhu (ORCID: https://orcid.org/0000-0003-2763-2377)
- Timothy Oh
- Jayesh Mehta
- Seema Singhal
Institutions
- Northwestern University (US)
- University of California, San Francisco (US)
- Northwestern Medicine (US)
Publication Details
- Journal
- eJHaem
- Published
- 2026-03-27
- DOI
- https://doi.org/10.1002/jha2.70277
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00